About Assertio (ASRT)
Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Susp... Read more
- USD9.29
- USD9.39
- USD9.19
- USD15.15
- -18.40%
- 137M
- 47.30k
- 59M
- 7.71
- -25.70%
Stock News
50 minutes ago
The top 10 jobs in the U.S. for 2026 all pay $100,000 or more, according to Indeed
CNBC
57 minutes ago
American stocks underperformed last year. Deutsche Bank says it could happen again.
MarketWatch
59 minutes ago
U.S. court allows a wind farm project to restart after Trump administration block, and a Danish stock surges
MarketWatch
2 hours ago
Global central bankers unite in defense of Fed Chair Jerome Powell
CNBC